In contrast, IL-6R blockade lowered systemic inflammation yet failed to correct cytopenia, highlighting a mechanistic distinction: IL-6 may help identify CRS, but IFN-γ drives it while simultaneously disrupting bone marrow recovery. This evidence concerns the gene IFNG and congenital rubella syndrome.